CASE STUDY

Elucidata x Celsius: 4x Faster Insights with Single-cell Infra

Key Highlights

  • Celsius- a Boston based biotech company, focused on leveraging single-cell RNA sequencing and machine learning to develop precision therapies for various complex inflammatory diseases.
  • They faced challenges with finding the right datasets, ensuring data quality, and building a robust and scalable infrastructure to store and analyze large-volumes of single-cell data.
  • Elucidata closely collaborated with their team over the last 4 years on building their end-to-end single-cell infrastructure for generating biological insights, providing high-quality single-cell datasets and data engineering expertise.
  • With our engineering expertise and deep domain expertise in single-cell, Elucidata helped Celsius bring 4x faster insights through a robust ML-infrastructure that put high data quality at its forefront.
Get your case study now
Thank you for showing interest!

To know more about us, book a demo here.
Oops! Something went wrong while submitting the form.

All Case Studies

Case study: Accelerated Target ID using ML-Ready data on Polly

Elucidata Delivers 100% Automated AAV Genome Sequencing Pipelines at 4X Lower Costs

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

AI-driven Chatbot Optimization: Achieving Human-Level Accuracy and Speed in Data Retrieval

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Elucidata Speeds Drug Toxicity Insights 4X by Integrating Clinical and Omics Data

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Elucidata Transforms RNAi Drug Discovery: 2X Faster Gene ID & Cell Annotation

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Elucidata x Hookipa: 7x Faster Insights In Translational Research

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Optimizing Diagnostics: Elucidata Doubles (2X) Sample to Report Speed

Read More
Request Demo